ClinicalTrials.govpublic full text
Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy
carcinoma, non-small-cell lung
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 429739
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.